Literature DB >> 11407988

A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes.

M Liovic1, J Stojan, P E Bowden, D Gibbs, A Vahlquist, E B Lane, R Komel.   

Abstract

Epidermolysis bullosa simplex is a hereditary skin blistering disorder caused by mutations in the KRT5 or KRT14 genes. More than 50 different mutations have been described so far. These, and reports of other keratin gene mutations, have highlighted the existence of mutation "hotspots" in keratin proteins at which sequence changes are most likely to be detrimental to protein function. Pathogenic mutations that occur outside these hotspots are usually associated with less severe disease phenotypes. We describe a novel K5 mutation (V186L) that produces a conservative amino acid change (valine to leucine) at position 18 of the 1A helix. The phenotype of this case is unexpectedly severe for the location of the mutation, which lies outside the consensus helix initiation motif mutation hotspot, and other mutations at this position have been associated in Weber--Cockayne (mild) epidermolysis bullosa simplex only. The mutation was confirmed by mismatch-allele-specific polymerase chain reaction and the entire KRT5 coding region was sequenced, but no other changes were identified. De novo K5/K14 (mutant and wild-type) filament assembly in cultured cells was studied to determine the effect of this mutation on filament polymerization and stability. A computer model of the 1A region of the K5/K14 coiled-coil was generated to visualize the structural impact of this mutation and to compare it with an analogous mutation causing mild disease. The results show a high level of concordance between genetic, cell culture and molecular modeling data, suggesting that even a conservative substitution can cause severe dysfunction in a structural protein, depending on the size and structure of the amino acid involved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407988     DOI: 10.1046/j.1523-1747.2001.01334.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Mutations Affecting Keratin 10 Surface-Exposed Residues Highlight the Structural Basis of Phenotypic Variation in Epidermolytic Ichthyosis.

Authors:  Haris Mirza; Anil Kumar; Brittany G Craiglow; Jing Zhou; Corey Saraceni; Richard Torbeck; Bruce Ragsdale; Paul Rehder; Annamari Ranki; Keith A Choate
Journal:  J Invest Dermatol       Date:  2015-06-15       Impact factor: 8.551

Review 2.  Keratin gene mutations in disorders of human skin and its appendages.

Authors:  Jean Christopher Chamcheu; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Mirjana Liovic; Hasan Mukhtar
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

3.  A mutation in the hair matrix and cuticle keratin KRTHB5 gene causes ectodermal dysplasia of hair and nail type.

Authors:  M Naeem; M Wajid; K Lee; S M Leal; W Ahmad
Journal:  J Med Genet       Date:  2006-03       Impact factor: 6.318

4.  Novel keratin 5 mutation in a family with epidermolysis bullosa simplex.

Authors:  Jiajia Gao; Xuebin Wang; Fang Zheng; Sufang Dong; Xueping Qiu
Journal:  Exp Ther Med       Date:  2015-10-16       Impact factor: 2.447

5.  Novel sporadic and recurrent mutations in KRT5 and KRT14 genes in Polish epidermolysis bullosa simplex patients: further insights into epidemiology and genotype-phenotype correlation.

Authors:  K Wertheim-Tysarowska; M Ołdak; A Giza; A Kutkowska-Kaźmierczak; J Sota; D Przybylska; K Woźniak; D Śniegórska; K Niepokój; A Sobczyńska-Tomaszewska; A M Rygiel; R Płoski; J Bal; C Kowalewski
Journal:  J Appl Genet       Date:  2015-10-02       Impact factor: 3.240

6.  Keratin Dynamics and Spatial Distribution in Wild-Type and K14 R125P Mutant Cells-A Computational Model.

Authors:  Marcos Gouveia; Špela Zemljič-Jokhadar; Marko Vidak; Biljana Stojkovič; Jure Derganc; Rui Travasso; Mirjana Liovic
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.